MZ-5030
N/A
Report date: 2025/03/11 17:08:38
NME
Base Information
Drug NameMZ-5030
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesShanghai Meizer Pharmaceuticals Co LtdShanghai Medicilon Inc
China Registration ClassClass 1 Chemical Drug in China
Develop Information
Active CompaniesShanghai Meizer Pharmaceuticals Co Ltd
Inactive CompaniesShanghai Medicilon Inc
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A